Home / Olmesartan Medoxomil / Japan
JP ATC C09CA08 · updated 2 Nov 2026
Olmesartan Medoxomil shortage in Japan
Is there an Olmesartan Medoxomil shortage in Japan?
Yes. As of 2 Nov 2026, 16 Olmesartan Medoxomil products are reported short in Japan, the first since 30 May 2025. No return date has been given. Main reason: increased demand.
Also short in Canada, Italy, Spain, Belgium. All countries.
Affected products in Japan
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| JP | オルメサルタンOD錠10mg「トーワ」 limited | Towa (Pensa) | 30 May 2025 | not given | Manufacturing problem |
| JP | オルメサルタンOD錠20mg「トーワ」 limited | Towa (Pensa) | 2 Apr 2026 | not given | Manufacturing problem |
| JP | オルメサルタンOD錠40mg「トーワ」 limited | Towa (Pensa) | 2 Apr 2026 | not given | Manufacturing problem |
| JP | オルメサルタンOD錠10mg「日医工」 limited | Nichi-Iko | 8 May 2026 | not given | Increased demand |
| JP | オルメサルタンOD錠20mg「日医工」 limited | Nichi-Iko | 8 May 2026 | not given | Increased demand |
| JP | オルメサルタンOD錠40mg「日医工」 limited | Nichi-Iko | 8 May 2026 | not given | Increased demand |
| JP | オルメサルタンOD錠5mg「日医工」 limited | Nichi-Iko | 8 May 2026 | not given | Increased demand |
| JP | オルメサルタンOD錠10mg「サワイ」 | Sawai | 10 Jun 2026 | not given | Other |
| JP | オルメサルタンOD錠20mg「サワイ」 | Sawai | 10 Jun 2026 | not given | Other |
| JP | オルメサルタンOD錠40mg「サワイ」 | Sawai | 10 Jun 2026 | not given | Other |
| JP | オルメサルタン錠10mg「日医工」 limited | Nichi-Iko | 12 Jun 2026 | not given | Increased demand |
| JP | オルメサルタン錠20mg「日医工」 limited | Nichi-Iko | 12 Jun 2026 | not given | Increased demand |
| JP | オルメサルタン錠40mg「日医工」 limited | Nichi-Iko | 12 Jun 2026 | not given | Increased demand |
| JP | オルメサルタン錠5mg「日医工」 limited | Nichi-Iko | 12 Jun 2026 | not given | Increased demand |
| JP | オルメサルタンOD錠5mg「サワイ」 limited | Sawai | 15 Jul 2026 | not given | Other |
| JP | オルメサルタンOD錠5mg「トーワ」 limited | Towa (Pensa) | 22 Oct 2026 | not given | Increased demand |
Source
MHLW (Ministry of Health, Labour and Welfare), supply status of prescription medicines. Official list. Prescription products under limited shipment or supply suspension (delistings excluded); one row per product.